Evidence map›Paper›PMID 22019632›Full record

ReviewFree radical biology & medicine2011

Nitric oxide-cyclic GMP signaling in stem cell differentiation.

Kalpana Mujoo, Joshua S Krumenacker, Ferid Murad

Open access · greenAbstract readReview
In one paragraph

Review in Free radical biology & medicine, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
2.3field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 48 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. The Role of Nitric Oxide in Stem Cell Biology.Antioxidants (Basel, Switzerland) · 2022
    Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Review
  13. Divergent modulation of normal and neoplastic stem cells by thrombospondin-1 and CD47 signaling.The international journal of biochemistry & cell biology · 2016
    Review
  14. [Preparation of rabbit monoclonal antibody against cGMP and development of competitive ELISA for cGMP].Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences · 2015
    Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 1 country.

Kalpana MujooBrown Foundation Institute of Molecular Medicine, Texas Therapeutics Institute, University of Texas Health Science Center at Houston, Houston, TX 77030, USA. Kalpana.Mujoo@uth.tmc.edu
Joshua S Krumenacker
Ferid Murad
Brown Foundation · USGeorge Washington University · USIndiana University School of Medicine

Funding

Role of Nitric Oxide and Cyclic GMP in Stem CellsR01GM076695 · NIGMS · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI GORENSTEIN, DAVID G · 2007 to 2010
$1.1M
NIGMS NIH HHS GM076695NIGMS NIH HHS R01 GM076695
6 · The paper itself

Abstract

The nitric oxide-cyclic GMP (NO-cGMP) pathway mediates important physiological functions associated with various integrative body systems including the cardiovascular and nervous systems. Furthermore, NO regulates cell growth, survival, apoptosis, proliferation, and differentiation at the cellular level. To understand the significance of the NO-cGMP pathway in development and differentiation, studies have been conducted both in developing embryos and in stem cells. Manipulation of the NO-cGMP pathway, by employing activators and inhibitors as pharmacological probes, and genetic manipulation of NO signaling components have implicated the involvement of this pathway in the regulation of stem cell differentiation. This review focuses on some of the work pertaining to the role of NO-cGMP in the differentiation of stem cells into cells of various lineages, particularly into myocardial cells, and in stem cell-based therapy.

Indexed as

Cell DifferentiationSignal TransductionAnimalsCyclic GMPHumansNitric OxideStem CellsCyclic GMPNitric Oxide

Identifiers

PMID22019632
PMCPMC3232180
OpenAlexW2017256062

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.